Phase 2 Acute Coronary Syndrome Clinical Trials
9 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–9 of 9 trials
Recruiting
Phase 2
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Heart DiseaseInflammationCoronary Arterial Disease (CAD)+3 more
Abcentra240 enrolled41 locationsNCT06927739
Recruiting
Phase 2
A Polypill for Acute Coronary Syndrome
Acute Coronary Syndrome
University of Texas Southwestern Medical Center1,000 enrolled1 locationNCT07032389
Recruiting
Phase 2
Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome
Acute Coronary Syndrome
Pontificia Universidad Catolica de Chile50 enrolled1 locationNCT05472337
Recruiting
Phase 2Phase 3
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
Ventricular DysfunctionDiabetesAcute Coronary Syndrome+1 more
University of Sao Paulo80 enrolled1 locationNCT06286878
Recruiting
Phase 2
POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
Acute Coronary SyndromeCYP2C19 Polymorphism
St. Antonius Hospital200 enrolled1 locationNCT05926271
Recruiting
Phase 2
A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI
Acute Coronary Syndrome
Shaanxi Micot Pharmaceutical Technology Co., Ltd.20 enrolled2 locationsNCT06533358
Completed
Phase 2
COCOMO-ACS Study: The Colchicine for coronary plaque modification in Acute Coronary Syndrome Study
Acute Coronary SyndromeCoronary Artery Disease
South Australian Health and Medical Research Insititute64 enrolled9 locationsACTRN12618000809235
Completed
Phase 2
"A Randomised, Double-Blind, Placebo-Controlled study to determine the safety and tolerability of E5555 in patients admitted to hospital with symptoms of Acute Coronary Syndrome"
Acute Coronary Syndrome
Eisai Ltd600 enrolled2 locationsACTRN12607000544471
Completed
Phase 2
A Study to Evaluate the Safety and Efficacy of Rivaroxaban in Combination with Aspirin Alone or with Aspirin and a Thienopyridine in Subjects with Acute Coronary Syndromes.
Acute Coronary Syndrome
Bayer Australia Limited3,490 enrolled1 locationACTRN12607000405415